Basal-like tumors are enriched in the basal lineage CD49f signature, while luminal markers such as NKX3.1, KRT18, and AR are elevated in luminal-like tumors, supporting the link between subtypes and the established prostate cancer biology [6]. This evidence concerns the gene AR and Familial prostate cancer.